MT
GILD icon

Midwest Trust’s Gilead Sciences GILD Stock Holding History

Midwest Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.3M Sell
9,315
-1,721
-16% -$241K 0.02% 329
2025
Q4 		$1.35M Buy
11,036
+1,923
+21% +$234K 0.02% 316
2025
Q3 		$1.01M Buy
9,113
+148
+2% +$16.8K 0.01% 342
2025
Q2 		$994K Buy
+8,965
New +$954K 0.01% 341

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Midwest Trust's GILD Position: Q1 2026 in Review

Midwest Trust reduced its Gilead Sciences (GILD) stake by 16% in Q1 2026, selling an estimated $241K and leaving 9,315 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #329.

Midwest Trust first reported a position in GILD in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.35M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Midwest Trust held 9,315 shares of Gilead Sciences worth $1.3M as of Q1 2026.
  • Midwest Trust sold 1,721 Gilead Sciences shares in Q1 2026, an estimated $241K.
  • Gilead Sciences made up 0.02% of Midwest Trust's portfolio in Q1 2026, its #329 holding.
  • Midwest Trust first reported a position in Gilead Sciences in Q2 2025 and has held it in 4 quarters since.
  • Midwest Trust's Gilead Sciences position peaked at $1.35M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.